Submitted by Anonymous (not verified) on 19 September 2023 - 11:12
Human medicines European public assessment report (EPAR): Tesavel, sitagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 10/01/2008, Revision: 28, Status: Authorised
Source: